2-[N-(2,4-Dichloro-5-methoxyphenyl)4-chlorobenzenesulfonamido]-N-(2,3-dichlorophenyl)acetamide

Catalog No. :
ACEUPT763
CAS No. :
338961-57-2
Molecular Formula :
C21H15Cl5N2O4S
Molecular Weight :
568.69

IUPAC Name:2-((4-chloro-N-(2,4-dichloro-5-methoxyphenyl)phenyl)sulfonamido)-N-(2,3-dichlorophenyl)acetamide

2-[N-(2,4-Dichloro-5-methoxyphenyl)4-chlorobenzenesulfonamido]-N-(2,3-dichlorophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[N-(2,4-Dichloro-5-methoxyphenyl)4-chlorobenzenesulfonamido]-N-(2,3-dichlorophenyl)acetamide
IUPAC Name2-((4-chloro-N-(2,4-dichloro-5-methoxyphenyl)phenyl)sulfonamido)-N-(2,3-dichlorophenyl)acetamide
Molecular FormulaC21H15Cl5N2O4S
Molecular Weight568.69
SMILESO=C(NC1=CC=CC(Cl)=C1Cl)CN(C2=CC(OC)=C(Cl)C=C2Cl)S(=O)(C3=CC=C(Cl)C=C3)=O
InChI KeyBZCMUMZSISMNDE-UHFFFAOYSA-N
Synonym2-(N-(4-CHLOROPHENYLSULFONYL)-2,4-DICHLORO-5-METHOXYPHENYLAMINO)-N-(2,3-DICHLOROPHENYL)ACETAMIDE;2-[N-(2,4-dichloro-5-methoxyphenyl)4-chlorobenzenesulfonamido]-N-(2,3-dichlorophenyl)acetamide;Acetamide, 2-[[(4-chlorophenyl)sulfonyl](2,4-dichloro-5-methoxyphenyl)amino]-N-(2,3-dichlorophenyl)-
CAS No.338961-57-2

Synthetic Route by SureRoute

1. ACEUPT763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEUPT763 route product structure diagram
    ACEUPT763338961-57-2
Inquiry

2. ACEUPT763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEUPT763 route product structure diagram
    ACEUPT763338961-57-2
Inquiry

Comments (0)